188 related articles for article (PubMed ID: 20405856)
1. Classification and virtual screening of androgen receptor antagonists.
Li J; Gramatica P
J Chem Inf Model; 2010 May; 50(5):861-74. PubMed ID: 20405856
[TBL] [Abstract][Full Text] [Related]
2. QSAR classification of estrogen receptor binders and pre-screening of potential pleiotropic EDCs.
Li J; Gramatica P
SAR QSAR Environ Res; 2010 Oct; 21(7-8):657-69. PubMed ID: 21120754
[TBL] [Abstract][Full Text] [Related]
3. Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.
Zhang L; Sedykh A; Tripathi A; Zhu H; Afantitis A; Mouchlis VD; Melagraki G; Rusyn I; Tropsha A
Toxicol Appl Pharmacol; 2013 Oct; 272(1):67-76. PubMed ID: 23707773
[TBL] [Abstract][Full Text] [Related]
4. In silico screening of estrogen-like chemicals based on different nonlinear classification models.
Liu H; Papa E; Walker JD; Gramatica P
J Mol Graph Model; 2007 Jul; 26(1):135-44. PubMed ID: 17293141
[TBL] [Abstract][Full Text] [Related]
5. Binary classification of a large collection of environmental chemicals from estrogen receptor assays by quantitative structure-activity relationship and machine learning methods.
Zang Q; Rotroff DM; Judson RS
J Chem Inf Model; 2013 Dec; 53(12):3244-61. PubMed ID: 24279462
[TBL] [Abstract][Full Text] [Related]
6. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
7. Screening of 397 chemicals and development of a quantitative structure--activity relationship model for androgen receptor antagonism.
Vinggaard AM; Niemelä J; Wedebye EB; Jensen GE
Chem Res Toxicol; 2008 Apr; 21(4):813-23. PubMed ID: 18324785
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for androgen receptor agonists and antagonists: interaction of SPEED 98-listed chemicals and related compounds with the androgen receptor based on an in vitro reporter gene assay and 3D-QSAR.
Tamura H; Ishimoto Y; Fujikawa T; Aoyama H; Yoshikawa H; Akamatsu M
Bioorg Med Chem; 2006 Nov; 14(21):7160-74. PubMed ID: 16876421
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of OASIS QSAR Models Using ToxCast™ in Vitro Estrogen and Androgen Receptor Binding Data and Application in an Integrated Endocrine Screening Approach.
Bhhatarai B; Wilson DM; Price PS; Marty S; Parks AK; Carney E
Environ Health Perspect; 2016 Sep; 124(9):1453-61. PubMed ID: 27152837
[TBL] [Abstract][Full Text] [Related]
10. Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor.
Fang H; Tong W; Branham WS; Moland CL; Dial SL; Hong H; Xie Q; Perkins R; Owens W; Sheehan DM
Chem Res Toxicol; 2003 Oct; 16(10):1338-58. PubMed ID: 14565775
[TBL] [Abstract][Full Text] [Related]
11. Computational models to predict endocrine-disrupting chemical binding with androgen or oestrogen receptors.
Chen Y; Cheng F; Sun L; Li W; Liu G; Tang Y
Ecotoxicol Environ Saf; 2014 Dec; 110():280-7. PubMed ID: 25282305
[TBL] [Abstract][Full Text] [Related]
12. QSAR classification models for the prediction of endocrine disrupting activity of brominated flame retardants.
Kovarich S; Papa E; Gramatica P
J Hazard Mater; 2011 Jun; 190(1-3):106-12. PubMed ID: 21454014
[TBL] [Abstract][Full Text] [Related]
13. Anti-androgen activity of polybrominated diphenyl ethers determined by comparative molecular similarity indices and molecular docking.
Yang W; Mu Y; Giesy JP; Zhang A; Yu H
Chemosphere; 2009 May; 75(9):1159-64. PubMed ID: 19324393
[TBL] [Abstract][Full Text] [Related]
14. Comparative molecular field analysis (CoMFA) model using a large diverse set of natural, synthetic and environmental chemicals for binding to the androgen receptor.
Hong H; Fang H; Xie Q; Perkins R; Sheehan DM; Tong W
SAR QSAR Environ Res; 2003; 14(5-6):373-88. PubMed ID: 14758981
[TBL] [Abstract][Full Text] [Related]
15. In silico methods in the discovery of endocrine disrupting chemicals.
Vuorinen A; Odermatt A; Schuster D
J Steroid Biochem Mol Biol; 2013 Sep; 137():18-26. PubMed ID: 23688835
[TBL] [Abstract][Full Text] [Related]
16. Binary classification models for endocrine disrupter effects mediated through the estrogen receptor.
Roncaglioni A; Piclin N; Pintore M; Benfenati E
SAR QSAR Environ Res; 2008; 19(7-8):697-733. PubMed ID: 19061085
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
Wang XS; Tang H; Golbraikh A; Tropsha A
J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
[TBL] [Abstract][Full Text] [Related]
18. QSAR classification models for the screening of the endocrine-disrupting activity of perfluorinated compounds.
Kovarich S; Papa E; Li J; Gramatica P
SAR QSAR Environ Res; 2012; 23(3-4):207-20. PubMed ID: 22352429
[TBL] [Abstract][Full Text] [Related]
19. Homology-modeled ligand-binding domains of medaka estrogen receptors and androgen receptors: a model system for the study of reproduction.
Cui J; Shen X; Yan Z; Zhao H; Nagahama Y
Biochem Biophys Res Commun; 2009 Feb; 380(1):115-21. PubMed ID: 19167350
[TBL] [Abstract][Full Text] [Related]
20. An integrated "4-phase" approach for setting endocrine disruption screening priorities--phase I and II predictions of estrogen receptor binding affinity.
Shi L; Tong W; Fang H; Xie Q; Hong H; Perkins R; Wu J; Tu M; Blair RM; Branham WS; Waller C; Walker J; Sheehan DM
SAR QSAR Environ Res; 2002 Mar; 13(1):69-88. PubMed ID: 12074393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
